1. Home
  2. BZUN vs CGEN Comparison

BZUN vs CGEN Comparison

Compare BZUN & CGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Baozun Inc.

BZUN

Baozun Inc.

HOLD

Current Price

$2.75

Market Cap

157.7M

ML Signal

HOLD

Logo Compugen Ltd.

CGEN

Compugen Ltd.

HOLD

Current Price

$1.68

Market Cap

148.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BZUN
CGEN
Founded
2007
1993
Country
Employees
N/A
N/A
Industry
Catalog/Specialty Distribution
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
157.7M
148.7M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
BZUN
CGEN
Price
$2.75
$1.68
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$4.00
AVG Volume (30 Days)
261.1K
248.6K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$6.10
N/A
Revenue Next Year
$3.93
$164.92
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.12
$1.13
52 Week High
$4.88
$2.38

Technical Indicators

Market Signals
Indicator
BZUN
CGEN
Relative Strength Index (RSI) 50.55 43.80
Support Level $2.62 $1.63
Resistance Level $2.73 $1.71
Average True Range (ATR) 0.12 0.08
MACD 0.00 -0.03
Stochastic Oscillator 51.35 26.25

Price Performance

Historical Comparison
BZUN
CGEN

About BZUN Baozun Inc.

Baozun Inc is engaged to provide its customers with end-to-end e-commerce solutions including the sales of apparel, home and electronic products, online store design and setup, visual merchandising and marketing, online store operations, customer services, warehousing and order fulfillment, as well as the holistic brand management, including strategy and tactic positioning, branding and marketing, retail and e-commerce operations, supply chain and logistics, and technology empowerment. It has two operating segments: E-Commerce (encompassing BEC and BZI) and Brand Management (representing BBM). The company generates maximum of its revenue from E-Commerce (encompassing BEC and BZI) segment.

About CGEN Compugen Ltd.

Compugen Ltd is a clinical-stage therapeutic discovery and development company utilizing its broadly applicable predictive computational discovery capabilities to identify novel drug targets and new biological pathways to develop therapeutics in the field of cancer immunotherapy. Its immuno-oncology pipeline consists of four clinical-stage programs, targeting immune checkpoints the company discovered computationally, COM701, COM902 and bapotulimab. The company's therapeutic pipeline of early-stage immuno-oncology programs consists of programs aiming to address various mechanisms of immune resistance, including myeloid targets.

Share on Social Networks: